Cao Sean Wuxiong
Cao Sean Wuxiong, CBDO, reported a transaction classified as exercise at NovaBridge Biosciences involving 104236.000000 shares. Reported holdings after the transaction were 374445.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 03, 2026
- Filing date
- Sep 08, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingNBP price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0002109966-26-000006 Ordinary Shares
- Transaction date
- Sep 03, 2026 Filed Sep 08, 2026, 09:51 PM · 5d delay
- Shares
- 104,236 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 374,445 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-2 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Bus. Development Officer
- F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
- F2
Reported securities are represented by 102,233 ADSs
- F3
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.
- F4
Reported securities are represented by 45,320 ADSs.
- F5
On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance v…
- F6
On June 22, 2026, the Reporting Person was granted 181,280 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the s…
0 other transactions
0 recent txs